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Post-Translational Modiﬁcations of Protein Backbones: Unique
Functions, Mechanisms, and Challenges
Manuel M. Müller*
Department of Chemistry, King’s College London, 7 Trinity Street, London SE1 1DB, United Kingdom
ABSTRACT: Post-translational modiﬁcations (PTMs) dramatically enhance the
capabilities of proteins. They introduce new functionalities and dynamically control
protein activity by modulating intra- and intermolecular interactions. Traditionally,
PTMs have been considered as reversible attachments to nucleophilic functional
groups on amino acid side chains, whereas the polypeptide backbone is often thought
to be inert. This paradigm is shifting as chemically and functionally diverse alterations
of the protein backbone are discovered. Importantly, backbone PTMs can control protein structure and function just as side
chain modiﬁcations do and operate through unique mechanisms to achieve these features. In this Perspective, I outline the
various types of protein backbone modiﬁcations discovered so far and highlight their contributions to biology as well as the
challenges in studying this versatile yet poorly characterized class of PTMs.
Proteins are assembled from a set of typically 20 α-L-aminoacids by iterative formation of amide bonds within the
ribosome. Following their biosynthesis, proteins are further
tailored through covalent modiﬁcations that introduce new
reactive groups not inherently present in the standard amino
acid building blocks, thus enabling new chemistries. Of equal
importance are modiﬁcations that dynamically or irreversibly
control the localization and activities of most natural proteins
and thus serve as regulators or even on/oﬀ switches. These so-
called post-translational modiﬁcations (PTMs)1 are typically
considered to occur primarily on amino acid side chains that
present a variety of nucleophilic groups that are easily targeted
by electrophilic cofactors. The peptide backbone, which makes
up approximately 50% of every protein’s mass, is often thought
to remain as forged by the ribosome. The rationale for this
conjecture is the inherently low reactivity of amides and the
notion that the backbone merely holds proteins together in one
(sequence) and three dimensions (structure). However, the
polypeptide backbone plays an active role in shaping protein
structure, and the properties of backbone atoms depend
critically on the surrounding amino acid sequence and local
conformation, which can profoundly alter amide reactivity.
These features make backbone atoms ideal targets for
spontaneous and enzymatic modiﬁcations. Indeed, peptides
and proteins featuring alterations to all components of the
backbone have been discovered (Figure 1), introducing new
functional groups and unique capabilities to ﬁne-tune protein
structures on demand. This Perspective is aimed at showcasing
the chemical and functional diversity of backbone PTMs
(bbPTMs), focusing on covalent modiﬁcations within proteins.
Modiﬁcation of termini,2 targeted proteolysis,1,3 splicing,4 and
proline isomerization5 have been excellently reviewed else-
where and are beyond the scope of this work. I will begin by
providing a glimpse into backbone modiﬁcations found in
peptide natural products to illustrate the rich palette of
biochemical possibilities for bbPTMs, followed by a more in-
depth treatment of bbPTMs that occur in large proteins.
Subsequently, I will highlight a series of examples to illustrate
how bbPTMs can (i) endow proteins with novel properties, (ii)
constitutively enhance protein stability and activity, and (iii)
serve as dynamic regulators of activity. To conclude, I will
discuss the unique mechanisms of action of bbPTMs and the
tools and challenges for their discovery, systematic cataloguing,
and functional characterization.
■ BACKBONE MODIFICATIONS ARE UBIQUITOUS IN
PEPTIDE NATURAL PRODUCTS
Ribosomally synthesized and post-translationally modiﬁed
peptide natural products (RiPPs) are prime examples of the
rich biochemistries that Nature harnesses to modify the
polypeptide backbone.6 These peptides are often deployed by
their producers, organisms from all domains of life, as toxins for
targeted chemical warfare against prey, predators, and
competitors for resources. Crucial to the activities of many
RiPPs are a plethora of PTMs that occur on the polypeptide
backbone (Figure 1).7 Masking of amide bonds that would
otherwise be susceptible to attack by proteases increases the
biochemical stability of peptides and can improve pharmaco-
logical properties such as membrane permeability. In addition,
backbone modiﬁcations can control local and global con-
formation and thus drive the formation of well-deﬁned three-
dimensional structures even in short peptides.8 bbPTMs
comprise chemically conservative modiﬁcations (such as the
conversion of an L- to a D-amino acid9 or the methylation of the
amide nitrogen10−12) and substantial alterations to the
backbone (including the formation of azole heterocycles13).6
Collectively, RiPPs serve as an inspiration for the types of
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bbPTMs that may be present in larger proteins and for
enzymes that install them.
■ PROTEIN BACKBONE MODIFICATIONS
INTRODUCE UNIQUE PROTEIN FUNCTIONS
In contrast to peptide natural products, the majority of proteins
beneﬁt from extensive tertiary interactions to stabilize their
folds, and many are not exposed to the harsh environments of
the extracellular space. Are bbPTMs nevertheless exploited by
proteins, as well? Indeed, bbPTMs have been discovered in a
range of proteins, in microorganisms and animals alike, where
they ﬁne-tune protein properties and even introduce unique
chemical motifs that confer novel functions. Perhaps most
prominently, ﬂuorescent proteins such as GFP from the
jellyﬁsh Aequorea victoria mature through a series of bbPTMs
that establish the ﬂuorophore core (Figure 2a,b).14 Nucleo-
philic attack of the amide nitrogen of Gly67 on the preceding
peptide bond results in the formation of a ﬁve-membered ring.
Subsequent elimination of water and oxidation of Tyr66 into a
Cα−Cβ unsaturated derivative yield a conjugated π-system
spanning backbone atoms from three adjacent residues that
forms the basis for ﬂuorescence. What allows this reaction to
occur is that when the protein folds, the amide bonds involved
are juxtaposed and their reactivities tuned by adjacent
functional groups. The cofactor 4-methylidene-5-imidazole-5-
one (MIO) is formed in a similar manner. Harnessed by amino
acid ammonia lyases and mutases from prokaryotes to
mammals, MIO is generated by cyclization and dehydration
of a tripeptide motif to introduce an electrophile within their
active sites (Figure 2c,d).15 These examples represent
spontaneous, constitutive maturation processes that demon-
strate the malleability of the protein backbone and the types of
novel structures that can be accessed through its modiﬁcation.
Figure 1. Examples of post-translational modiﬁcations of the polypeptide backbone (bbPTMs). This Perspective focuses on covalent modiﬁcations
at Cα (blue dotted lines), the amide N (green), and CO (orange) as well as backbone extensions (purple) on proteins (yellow shaded areas).
Selected protein examples for the depicted modiﬁcations are listed below. Additional bbPTMs found in ribosomally synthesized and post-
translationally modiﬁed peptides (RiPPs) are shaded with a blue background.6 MCR represents methyl-coenzyme M reductase.
Figure 2. Novel functions provided by backbone modiﬁcations. (a and b) Maturation of the GFP ﬂuorophore14 via a backbone cyclization,
dehydration, and oxidation [Protein Data Bank (PDB) entry 1EMA].16 (c and d) Formation of the electrophilic cofactor 4-methylidene-5-imidazole-
5-one (MIO)15 via backbone cyclization and dehydration steps (PDB entry 1GKJ).17
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■ PROTEIN BACKBONE MODIFICATIONS
MODULATE PROTEIN ACTIVITY AND STABILITY
Backbone modiﬁcations can also improve existing functions by
increasing enzyme stability and activity. Such bbPTMs are
introduced via spontaneous maturation processes in cis (as
discussed above for GFP and MIO) or by speciﬁc enzymes in
trans. A case in point for autocatalytic bbPTMs is the Cα
hydroxylation of an active site proline in a bacterial
polysaccharide deacetylase (Figure 3a).18 The additional OH
group, installed under aerobic conditions, provides a hydrogen
bond to stabilize the tetrahedral intermediate and thus
accelerates deacetylase activity.18 Another series of spontaneous
bbPTMs involves asparagine and aspartate residues. These
reactions are initiated by nucleophilic attack of a backbone
amide nitrogen on the side chain amide (Asn) or, to a lesser
extent, acid (Asp).19,20 The resulting succinimide is typically
unstable and is hydrolyzed to provide either Asp or its β-linked
derivative, isoAsp (Figure 4a). Succinimides are also prone to
epimerization, leading to the formation of D-Asp and D-isoAsp.
Accordingly, isoAsp and its mirror image accumulate over time
and are thus often detected in naturally and artiﬁcially aged
proteins, where their formation has been implicated in protein
damage and age-related human pathologies.19 Importantly,
however, there are cases in which Asn-related backbone
modiﬁcations occur constitutively in “young” proteins and
confer desirable properties. A recent study of glutaminase from
a hyperthermophilic archaeon revealed that a stable succinimide
moiety confers extraordinary stability on this enzyme (Figure
3b).21 The succinimide, shielded from hydrolysis by surround-
ing anionic residues, introduces a conformational constraint
that is important for protein stability. Consequently, disrupting
the succinimide by site-directed mutagenesis diminishes the
protein’s resilience to chemical and thermal denaturation.21
Similarly, an isoAsp residue has been observed in MurA,22 an
enzyme involved in bacterial cell wall biosynthesis (Figure 3c).
It is likely that the additional methylene group of isoAsp
triggers the formation of an unusual turn structure, which might
also enhance protein stability, although this conjecture has not
been experimentally tested.
A suite of interesting, enzymatically installed bbPTMs has
been discovered in archaeal methyl-coenzyme M reductase, a
key enzyme in methane metabolism (Figure 3d).23−25
Didehydroaspartate,25 α-methylglutamine,24 and thioglycine24
(substitution of the carbonyl oxygen of a glycine residue with a
sulfur atom) have been detected in several homologues near the
Figure 3. Structural context of protein backbone modiﬁcations. (a) α-Hydroxyproline in the active site of Bacillus cereus peptidoglycan N-
acetylglucosamine deacetylase (PDB entry 4L1G).18 (b) Stable succinimide residue in glutaminase from the hyperthermophilic archaeon Pyrococcus
horikoshii (PDB entry 1WL8).21 (c) Isoaspartate-containing hairpin in MurA from Enterobacter cloacae (UDP-N-acetylglucosamine 1-
carboxyvinyltransferase, PDB entry 1EJC).22 (d) bbPTMs discovered in the active site region of methyl-coenzyme M reductase from the
methanogenic archaeon Methanothermobacter marburgensis (left, α-methylglutamine; center, thioglycine; right, dehydroaspartate; PDB entry
5A0Y).23,25 A potential n → π* interaction28 involving thioglycine is indicated by a dashed line.
Figure 4. Installation of bbPTMs by spontaneous and enzymatic
pathways. (a) Spontaneous backbone rearrangements of Asn and Asp
residues into isoAsp. IsoAsp formation and reversion may be catalyzed
indirectly (red steps) by a glycosyltransferase (OGT) via a glycosyl
aspartate intermediate29 and by protein isoaspartate methyltransferase
(PIMT),30 respectively. (b) Proposed mechanism13,27 for thioamide
formation in methyl-coenzyme M reductase via a kinase that targets
the backbone amide, YcaO, and an auxiliary protein of unknown
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active site, attesting to their importance. A candidate
oxidoreductase for didehydroaspartate formation has been
postulated,25 and it has been demonstrated that the Cα-methyl
group of α-methylglutamine originates from the cofactor S-
adenosylmethionine, but a speciﬁc methyltransferase has not
been identiﬁed.26 Recently, the enzymes responsible for
thioglycine formation, a backbone kinase (YcaO) and an
auxiliary protein of unknown function (TfuA), have been
identiﬁed through homologues involved in natural product
thioamide biosynthesis pathways (Figure 4a).13,27 Deleting the
genes encoding the modifying enzymes in a methanogenic
archaeon precluded thioamide formation and yielded a viable
strain with conditional growth defects (for example, at high
temperatures).27 This result suggests that thioamide formation
ﬁne-tunes the properties of methyl-coenzyme M reductase
rather than being essential for catalytic activity.27 Importantly,
the observation that enzymes involved in decorating
ribosomally synthesized peptides have homologues that operate
on large proteins supports the hypothesis that any modiﬁcation
found in peptides may also be found in proteins.
■ REGULATORY ROLES OF PROTEIN BACKBONE
MODIFICATIONS
Side chain PTMs are often harnessed to switch proteins on or
oﬀ, as illustrated by the well-known role of protein
phosphorylation in signaling cascades. This type of control is
mediated by enzymes to dynamically install and remove PTMs
(e.g., kinases and phosphatases, respectively, in the case of
phosphorylation), but little is known about reversibility in the
context of backbone modiﬁcations. An intriguing exception is
the formation and reversal of isoAsp linkages. A dedicated
protein isoaspartate methyltransferase (PIMT) catalyzes the
methylation of isoAsp at the free α-carboxylate to accelerate
succinimide formation, leading to the accumulation of Asp over
several repair cycles (Figure 4a).30 Recently, it was also found
that the formation of isoAsp from Asp can be enzymatically
promoted by glycosyltransferases [through the formation of a
glycosyl aspartate intermediate (Figure 4a)] and possibly other
transferases, as well.29 The existence of enzymes that catalyze
the formation and reversal of this bbPTM suggests that it is
harnessed for dynamic regulatory purposes.
The spontaneous nature of isoAsp formation provides an
additional regulatory mechanism. This process can act as a
molecular timer, turning on or oﬀ protein function in a time-
dependent manner. The rate of isoAsp formation is strongly
inﬂuenced by the surrounding sequence as well as the local
structure, with half-times ranging from hours to centuries.20
These time scales represent typical lifetimes of proteins and
organisms. However, given that the time scales of this reaction
are evolutionarily (protein sequence and structure) and
biochemically controlled,20 it is possible that isoAsp formation
is actively harnessed for signaling. Indeed, several components
of apoptotic pathways,31,32 chromatin,33,34 and the cell adhesion
machinery35 are believed to signal through this bbPTM, and
more detailed structure−function studies will be required to
illuminate their mechanism of action.
Backbone modiﬁcations are also exploited to regulate
proteins directly in active sites. For example, human protein
tyrosine phosphatase 1B is switched oﬀ by masking the catalytic
cysteine residue as a sulfenyl-amide with the adjacent backbone
amide nitrogen (Figure 5a).36 Cyclization is controlled by the
cellular redox state; reactive oxygen species promote S−N bond
formation, whereas the cellular reducing agent glutathione
reverses it. Another case in point is the phosphothreonine lyase
OspF, deployed by pathogens to inactivate their hosts’ immune
signaling pathways (Figure 5b). This enzyme catalyzes the
elimination of phosphate from phosphothreonine residues in
key signal transduction proteins, thereby inactivating the target
and leaving an α−β unsaturated residue at the site of action.37
In this case, the backbone modiﬁcation does not provide a
unique function but is merely a byproduct in the inactivation of
a signaling pathway. It it worth noting that homologous
enzymes install α−β unsaturated residues in peptide natural
products,38 lending further support to the notion that peptide-
modifying enzymes can inspire the identiﬁcation of bbPTMs in
proteins.
Figure 5. Regulatory protein bbPTMs. (a) Switching of human protein tyrosine phosphatase 1B activity by reactive oxygen species (ROS) and
glutathione (GSH).36 (b) Inactivation of host signaling pathways by the pathogenic phosphothreonine lyase OspF (red).37
Figure 6. Conformational eﬀects of protein backbone modiﬁcations. (a) Backbone modiﬁcations alter the positioning of side chains, exempliﬁed by
L-Asp and its derivatives. A green plate is drawn through the N−Cα−C(O) plane for reference. In the case of isoAsp, the plate is drawn through
N−Cα−Cβ. Side chain rotatable bonds are indicated with dashed arrows. For the sake of clarity, only one of the backbone dihedral angles (red) is
shown in each panel. (b) Ramachandran plots of native and selected modiﬁed amino acids indicating favorable conformations (shaded areas) and
regions corresponding to α-helices, β-sheets, and selected β-turns. Indices in type I and II turns designate the i + 1 and i + 2 residues. (c) Diﬀerences
in bond lengths between thioamide and amide groups.46
Biochemistry Perspective
DOI: 10.1021/acs.biochem.7b00861
Biochemistry XXXX, XXX, XXX−XXX
D
■ HOW DO PROTEIN BACKBONE MODIFICATIONS
CONTROL PROTEIN FUNCTION AND STABILITY?
The examples described above demonstrate that bbPTMs exert
their eﬀects not only by contributing new reactivities but also
through unique conformational mechanisms. Speciﬁcally, they
can ﬁne-tune the position of existing functional groups (Figure
6a) and dramatically alter the trajectory of the polypeptide
backbone (Figure 6b). For instance, D-amino acids reposition
their own side chain and provide access to dihedral angles that
are otherwise accessible only to glycine, which is particularly
favorable for inducing turns (Figure 6b).39,40 Cα methylation
stabilizes α-helices by reducing the favorable φ and ψ angle
space (Figure 6b).41 This eﬀect possibly explains the presence
of the α-methyl-Gln residue in a helix that packs against the
active site of methyl-coenzyme M reductase (Figure 3b).24
Cyclically constrained residues such as succinimides rigidify the
backbone and provide access to unusual dihedral angles (Figure
3b).21 Reduced ﬂexibility is a hallmark of thermophilic
enzymes,42 and it is conceivable that succinimide formation,
which has been shown to contribute to the thermostability of
glutaminase,21 is similarly harnessed to stabilize other hyper-
thermophilic proteins. isoAsp building blocks change the
spacing of adjacent residues in terms of distances and angles
because they contain an additional sp3−sp3 carbon−carbon
bond that favors dihedral angles θ of 60°, 180°, and −60°
(Figures 3c and 6a).43 N-Alkylation has a profound impact on
structure through eﬀects on backbone dihedral angles, amide
bond cis/trans equilibrium, and hydrogen bonding,12 essential
for regular secondary structures in proteins. Thioamides exhibit
steric and electronic properties diﬀerent from those of amides,
resulting, for example, in diﬀerent CX bond lengths (Figure
6c), H-bonding properties, and n → π* interactions44 and the
possibility of photochemically triggering thioamide cis/trans
isomerization.45 Several of these factors have been invoked to
rationalize the presence of a thioglycine residue in the active
site of methyl-coenzyme M reductase,27 and its conformation is
compatible with a stabilizing n → π* interaction28 that could
further contribute to aligning active site residues (Figure 3d).
Thus, bbPTMs provide a range of possibilities for locally
reshaping peptide conformation, and as exempliﬁed by
glutaminase (Figure 3b), these changes can propagate to alter
global protein properties.
■ IDENTIFICATION OF PROTEIN BACKBONE PTMS,
FROM SERENDIPITOUS DISCOVERIES TO “OMICS”
To date, most protein backbone modiﬁcations were discovered
serendipitously. Careful interpretations of electron density
maps from X-ray crystallography studies have revealed the
existence of most of the bbPTMs discussed above (see, for
example, Figure 3).15,16,18,21−25 Structural biology represents an
important tool kit in the identiﬁcation and characterization of
bbPTMs but is inherently limited in throughput and favors
autocatalytic modiﬁcations that manifest during recombinant
protein production. To gain a systematic understanding of the
distribution of bbPTMs, new approaches are required that can
also address regulatory PTMs, which occur in a spatially,
temporally, and stoichiometrically restricted manner. Protein
mass spectrometry, in conjunction with enrichment strategies
(commonly employed for side chain modiﬁcations), will be
instrumental in this process (Figure 7a).47 In the context of
bbPTMs, such proteomics strategies have been developed and
successfully applied only to search for new isoAsp- and
succinimide-containing proteins (Figure 7b). Current strategies
hinge upon identifying isoAsp by labeling this residue with the
speciﬁc “repair” enzyme PIMT or unique fragmentation
patterns of β-peptidic linkages observed through high-end
mass spectrometry.48,49 Such eﬀorts were used to catalogue the
“isoAspartome” for example in bacteria50 and human cells,51 as
well as in cell lines, tissues, and ﬂuids from mice lacking
PIMT.52−54 Of particular interest is the ﬁnding that ribosomal
protein S11 in Escherichia coli exhibits close to stoichiometric
amounts of isoAsp, suggesting that this modiﬁcation is
functionally important, although its speciﬁc role is still
unclear.50 Moreover, enrichment protocols based on nucleo-
philic trapping of the methylester or succinimide intermediate
have been developed to increase the sensitivity of detection
(Figure 7b).55
Similar technologies for enriching and identifying other
bbPTMs will be needed to fully appreciate the role of these
modiﬁcations in biology. As for side chain PTMs, aﬃnity
reagents such as antibodies (or synthetic analogues thereof)56,57
Figure 7. Selected tools for studying the distribution and function of bbPTMs. (a) General proteomics approach for systematic characterization of
the distribution of PTMs. (b) Strategies for the identiﬁcation of isoAsp-containing proteins. (c) Preparation of site-speciﬁcally modiﬁed proteins via
synthetic biology (left) and protein (semi)synthesis (right). aaRS represents aminoacyl-tRNA synthetase.
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as well as chemical reactivity-based strategies will likely be
instrumental in this process. In this regard, antibodies that
recognize speciﬁc isoAsp residues, for example, in amyloids, eye
lens crystallin, and histones have been described,33,58,59 but
monoclonal versions that bind bbPTMs regardless of sequence
context are still lacking. Presumably, such pan-speciﬁc reagents
will be easier to elicit for modiﬁcations that involve major
changes to the backbone (e.g., azole heterocycles) and more
challenging for more subtle modiﬁcations (e.g., N-methyl and
D-amino acids). Where known, the enzymes that are
responsible for modifying the polypeptide backbone might
also ﬁnd application in the identiﬁcation of unknown substrates
as discussed above for PIMT. Chemical genetic strategies
originally developed for interrogating kinases via engineered
kinase−ATP analogue pairs (“bump-hole method”),60 which
allows covalent capture of substrates,61 might be harnessed for
similar quests involving bbPTM−enzyme systems. It is worth
noting that lysine methyltransferases have recently been
repurposed to transfer alkyne handles enabling isolation of
their products.62 These modiﬁed cofactor analogues might also
be accommodated by suitably engineered backbone methyl-
transferases.
■ TOOLS FOR DETERMINING PROTEIN BACKBONE
PTM FUNCTIONS
In many cases, the exact role that backbone modiﬁcations play
is unclear, and there is a pressing need for eﬀective tools to
characterize them. Many technologies developed for side chain
PTMs can be adapted, but additional innovations are necessary
to accommodate the speciﬁc requirements of bbPTMs. Insight
into the function of PTMs in cells is typically gleaned from
phenotypic characterization of strains that constitutively
produce or are devoid of a given modiﬁcation. Where known,
genetic or chemical manipulation of the installing enzymes or
mutation of the modiﬁed residues is exploited to interrogate
PTMs. Currently, however, few such enzymes are known in the
context of bbPTMs, and backbone atoms cannot be changed
directly by site-directed mutagenesis.
To understand how bbPTMs control proteins mechanisti-
cally, biochemical and biophysical dissection of site-speciﬁcally
modiﬁed proteins will be crucial. Where available, enzymes that
install PTMs can be deployed to install modiﬁcations. Often,
however, insuﬃcient activity and speciﬁcity of enzymes in vitro
or in recombinant hosts can hamper these eﬀorts. Synthetic
proteins have been harnessed extensively to explore the roles of
side chain PTMs, for example, in chromatin biochemistry,63
and are ripe for investigating protein backbone modiﬁcations.
In fact, a variety of building blocks with unnatural backbones
have already been installed in proteins using synthetic chemical
and biological methods, frequently for biophysical investiga-
tions of protein folding.64 To inﬁltrate ribosomal protein
synthesis with backbone-modiﬁed building blocks, chemical
and biological methods for charging tRNAs with unnatural
monomers such as N-alkyl- or Cα-dialkyl amino acids have been
developed (Figure 7c).65−67 In certain cases, the ribosome itself
and other elements of the translation machinery must be
reengineered to promote the synthesis of modiﬁed backbones
in addition to standard peptide bonds. This challenging feature
has been achieved, for example, through selecting ribosomes
that are sensitive to backbone-modiﬁed versions of the
translation-inhibiting antibiotic puromycin.68,69 Chemical meth-
ods, i.e., solid phase peptide synthesis, are ideally suited for the
incorporation of backbone-modiﬁed building blocks, and
specialized protocols for accommodating a variety of bbPTMs
have been developed. Amide bonds involving D-amino acids,
Cα-dialkyl amino acids, β-amino acids (i.e., isoAsp), and N-
methyl amino acids can be formed using standard coupling
chemistries, although the added bulk of some of these
modiﬁcations can pose a challenge.70 Thioamides can be
accessed through the substitution of sulfur for oxygen at the
building block level,45 and cyclic structures such as oxazoles can
be incorporated via dipeptide analogues.71 Importantly,
synthetic peptides can be elaborated into full-length proteins
bearing site-speciﬁc bbPTMs through the use of convergent,
chemo-selective strategies. Native chemical ligation72 is an ideal
method for this purpose because both synthetic and
recombinant fragments can be employed and its mild
conditions are compatible with most backbone modiﬁcations
(Figure 7c). A few backbone modiﬁcations can even be
installed by site-speciﬁc modiﬁcation of full-length proteins.
Dehydroalanine, for example, can be accessed selectively from
cysteine residues via mild elimination reactions.73 Thus, a suite
of chemical biology tools are available to probe in detail the
functional consequences and mechanism of action of protein
backbone modiﬁcations, but adapting these methods for
speciﬁc backbone chemistries as well as the development of
new technologies will be required to fully appreciate the role of
protein backbone modiﬁcations in biology.
■ SUMMARY
The examples presented throughout this Perspective demon-
strate that site-speciﬁc PTMs of protein backbones are
chemically feasible and biologically relevant. The functions
and mechanisms of action of bbPTMs are as diverse as their
chemistries. Autocatalytic condensation reactions on the
backbone provide unique conjugated systems with valuable
photophysical and catalytic properties. The spontaneous nature
of the formation of some bbPTMs can be harnessed for
molecular timers as well as pH or redox sensors and thus
provide elegant ways to regulate signaling pathways. In
addition, bbPTMs contribute to pushing the limits of protein
stability and activity by ﬁne-tuning the positioning of functional
groups and through new structural motifs. Such features are
particularly important for proteins that operate under extreme
conditions, including hyperthermophilic proteins and enzymes
situated in high-ﬂux metabolic pathways.
Despite these fascinating examples, there is little insight into
the distribution of protein backbone modiﬁcations. While
bbPTMs have been observed in proteins from all domains of
life, to date, enzymes that speciﬁcally introduce bbPTMs into
proteins have been identiﬁed only in prokaryotes.27,37 Never-
theless, enzymes with backbone-modifying activities also exist
in multicellular eukaryotes. For example, animals harbor
enzymes to install D-amino acids in peptides;74,75 fungi exploit
backbone amide N-methyltransferases that produce bioactive
peptides,10,11 and catalysis of formation of isoAsp by a human
enzyme has been demonstrated in vitro.29 Moreover, it is
currently unclear whether speciﬁc binding domains for
recognizing bbPTMs exist. Such domains are common for
side chain modiﬁcations and orchestrate tunable protein−
protein interaction networks. Certainly, bbPTMs can modulate
protein−protein interactions by reshaping linear motifs and
binding surfaces, yet the extent of their use in signaling and
their interplay with side chain PTMs remain to be explored.
Recent improvements in all aspects of protein science,
including structural biology and analytical and synthetic
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methodology, as well as the availability of genetic tools in
diverse organisms make the study of bbPTMs a timely pursuit.
Systematic application of this reﬁned tool kit and the
development of novel strategies will be required to tie the
isolated case studies of bbPTMs into a cohesive ﬁeld of
biochemistry. The resulting understanding of the properties of
naturally occurring backbone modiﬁcations will likely also
inspire new techniques for artiﬁcially manipulating proteins.
Following the success of backbone engineering in peptides,
protein backbone engineering may pave the way to therapeutic
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